The role of radiomics in prostate cancer radiotherapy

R Delgadillo, JC Ford, MC Abramowitz… - Strahlentherapie und …, 2020 - Springer
Abstract “Radiomics,” as it refers to the extraction and analysis of a large number of
advanced quantitative radiological features from medical images using high-throughput …

The promise and future of radiomics for personalized radiotherapy dosing and adaptation

RB Ger, L Wei, I El Naqa, J Wang - Seminars in Radiation Oncology, 2023 - Elsevier
Quantitative image analysis, also known as radiomics, aims to analyze large-scale
quantitative features extracted from acquired medical images using hand-crafted or machine …

CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study

H Li, R Zhang, S Wang, M Fang, Y Zhu, Z Hu… - Frontiers in …, 2020 - frontiersin.org
Objectives: To identify a computed tomography (CT)-based radiomic signature for predicting
progression-free survival (PFS) in stage IV anaplastic lymphoma kinase (ALK)-positive non …

Generative adversarial networks can create high quality artificial prostate cancer magnetic resonance images

IRL Xu, DJ Van Booven, S Goberdhan, A Breto… - Journal of personalized …, 2023 - mdpi.com
The recent integration of open-source data with machine learning models, especially in the
medical field, has opened new doors to studying disease progression and/or regression …

Phase I trial of MRI-guided prostate cancer lattice extreme ablative dose (LEAD) boost radiation therapy

A Pollack, FM Chinea, E Bossart, D Kwon… - International Journal of …, 2020 - Elsevier
Purpose A phase I clinical trial was designed to test the feasibility and toxicity of
administering high-dose spatially fractionated radiation therapy to magnetic resonance …

Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with …

M Gibbons, JP Simko, PR Carroll… - Magnetic Resonance …, 2023 - Elsevier
Multi-parametric MRI (mpMRI) has proven itself a clinically useful tool to assess prostate
cancer (PCa). Our objective was to generate PCa risk maps to quantify the volume and …

Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI

R Stoyanova, O Zavala-Romero, D Kwon, AL Breto… - Cancers, 2023 - mdpi.com
Simple Summary In this study, we built clinical-and radiomics-based models to predict
lesions/patients at low risk based on a combined clinical-genomic classification system …

Visualising spatial heterogeneity in glioblastoma using imaging habitats

M Waqar, PJ Van Houdt, E Hessen, KL Li, X Zhu… - Frontiers in …, 2022 - frontiersin.org
Glioblastoma is a high-grade aggressive neoplasm characterised by significant intra-tumoral
spatial heterogeneity. Personalising therapy for this tumour requires non-invasive tools to …

Multi‐parametric MRI (mpMRI) for treatment response assessment of radiation therapy

C Wang, KR Padgett, MY Su, EA Mellon… - Medical …, 2022 - Wiley Online Library
Magnetic resonance imaging (MRI) plays an important role in the modern radiation therapy
(RT) workflow. In comparison with computed tomography (CT) imaging, which is the …

Habitats in DCE-MRI to predict clinically significant prostate cancers

NA Parra, H Lu, J Choi, K Gage, J Pow-Sang, RJ Gillies… - Tomography, 2019 - mdpi.com
Prostate cancer identification and assessment of clinical significance continues to be a
challenge. Routine multiparametric magnetic resonance imaging has shown to be useful in …